PT  - JOURNAL ARTICLE
AU  - Hamish Houston
AU  - Ankur Gupta-Wright
AU  - Edward Toke-Bjolgerud
AU  - James Biggin-Lamming
AU  - Laurence John
TI  - Diagnostic accuracy and utility of SARS-CoV-2 antigen lateral flow assays in medical admissions with possible COVID-19
AID  - 10.1101/2021.01.27.21250428
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.27.21250428
4099  - http://medrxiv.org/content/early/2021/01/29/2021.01.27.21250428.short
4100  - http://medrxiv.org/content/early/2021/01/29/2021.01.27.21250428.full
AB  - We evaluated diagnostic accuracy of the Innova SARS-CoV-2 Antigen Rapid Qualitative Test compared to SARS-CoV-2 RT-PCR from nasopharyngeal swabs in adult admissions who met the COVID-19 case definition at a busy acute hospital in the UK. We found the Innova SARS-CoV-2 Antigen Rapid Qualitative Test had a good specificity in patients with symptoms of COVID-19 presenting to hospital. The Innova LFA can be used to rapidly identify COVID-19 cases amongst hospital admissions meeting the COVID-19 case definition, allowing patients to be allocated to COVID-19 cohort areas.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study received no specific grant from any funding agency in the public, commercial or not-for-profit sector. The manufacturer (Lotus Global Company, London, UK) had no role in the study conception, design, data analysis or manuscript preparation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the London North West University Hospitals Trust Research and Development Committee, and given the SARS-CoV-2 antigen lateral flow assay was implemented as part of routine clinical care and this was a retrospective review using routinely collected clinical data, they deemed formal ethical approval was not required. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and statistical code available upon reasonable request.